Charles River Labs Files 8-K: Agreements, Personnel Changes
Ticker: CRL · Form: 8-K · Filed: May 7, 2025 · CIK: 1100682
| Field | Detail |
|---|---|
| Company | Charles River Laboratories International, INC. (CRL) |
| Form Type | 8-K |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, management-change, corporate-action
Related Tickers: CRL
TL;DR
CRL filed an 8-K detailing new agreements and exec changes. Keep an eye on this.
AI Summary
Charles River Laboratories International, Inc. announced on May 7, 2025, the entry into a material definitive agreement, the departure of directors or certain officers, the election of directors, and the appointment of certain officers. The filing also includes compensatory arrangements for certain officers and Regulation FD disclosures. The company is involved in commercial physical and biological research.
Why It Matters
This 8-K filing indicates significant corporate actions including new agreements and changes in leadership, which could impact the company's strategic direction and operational stability.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and changes in officers/directors, which can introduce uncertainty and potential strategic shifts.
Key Players & Entities
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (company) — Registrant
- May 7, 2025 (date) — Date of Report
- 001-15943 (other) — SEC File Number
- 06-1397316 (other) — EIN
FAQ
What is the nature of the material definitive agreement entered into by Charles River Laboratories?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the summary information.
Who are the directors or officers departing from Charles River Laboratories?
The filing states the departure of directors or certain officers, but their names and specific roles are not detailed in the provided summary.
Were there any new elections or appointments of officers or directors?
Yes, the filing confirms the election of directors and the appointment of certain officers.
Does the filing include information on compensatory arrangements for officers?
Yes, the filing explicitly mentions compensatory arrangements of certain officers.
What is the primary business of Charles River Laboratories International, Inc. according to the filing?
Charles River Laboratories International, Inc. is primarily involved in commercial physical and biological research, with a Standard Industrial Classification code of 8731.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 7, 2025 regarding CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).